Detalhe da pesquisa
1.
Nation-wide cohort study of remission induction therapy using rituximab in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: Effectiveness and safety in the first 6 months.
Mod Rheumatol
; 33(6): 1117-1124, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478050